This is a preview of subscription content, log in via an institution to check access.
References
H. Watanabe, A. Fujiyama, M. Hattori, et al., “DNA Sequence and Comparative Analysis of Chimpanzee Chromosome 22,” Nature 429, 382 (2004).
C. S. Lai, S. E. Fisher, J. A. Hurst, et al., “A Forkhead-Domain Gene Is Mutated in a Severe Speech and Language Disorder,” Nature 413, 519 (2001).
J. Bond, E. Roberts, G. H. Mochida, et al., “ASPM Is a Major Determinant of Cerebral Cortical Size,” Nat. Genet. 32, 316 (2002).
A. P. Grigorenko and E. I. Rogaev, “Molecular Basis of Alzheimer’s Disease,” Mol. Biol. 41, 331 (2007) [Mol. Biol. 41, 294 (2007)].
E. I. Rogaev, R. Sherrington, E. A. Rogaeva, et al., “Familial Alzheimer’s Disease in Kindreds with Missense Mutations in a Gene on Chromosome 1 Related to the Alzheimer’s Disease Type 3 Gene,” Nature 376, 775 (1995).
R. Sherrington, E. I. Rogaev, Y. Liang, et al., “Cloning of a Gene Bearing Missense Mutations in Early-Onset Familial Alzheimer’s Disease,” Nature 375, 754 (1995).
A. P. Grigorenko, Yu. K. Molyaka, G. I. Korovaitseva, and E. I. Rogaev, “Novel Class of Polytopic Proteins with Domains Associated with Putative Protease Activity,” Biokhim. 67, 995 (2002) [Biochem. 67, 826 (2002)].
G. I. Korovaitseva, T. V. Shcherbatykh, N. V. Selezneva, et al., “Genetic Association between the Apolipoprotein E (AROE) Gene Alleles and Various Forms of Alzheimer’s Disease,” Genetika 37, 529 (2001).
A. Rovelet-Lecrux, D. Hannequin, G. Raux, et al., “APP Locus Duplication Causes Autosomal Dominant Early-Onset Alzheimer disease with Cerebral Amyloid Angiopathy,” Nat. Genet. 38, 24 (2006).
H. G. Brunner, M. R. Nelen, P. van Zandvoort, et al., “X-Linked Borderline Mental Retardation with Prominent Behavioral Disturbance: Phenotype, Genetic Localization, and Evidence for Disturbed Monoamine Metabolism,” Am. J. Hum. Genet. 52, 1032 (1993).
O. Cases, I. Seif, J. Grimsby, et al., “Aggressive Behavior and Altered Amounts of Brain Serotonin and Nore-pinephrine in Mice Lacking MAOA,” Science 268, 1763 (1995).
I. Chumakov, M. Blumenfeld, O. Guerassimenko, et al., “Genetic and Physiological Data Implicating the New Human Gene G72 and the Gene for D-Amino Acid Oxidase in Schizophrenia,” Proc. Nat. Acad. Sci. U.S.A. 99, 13 675 (2002).
“International Schizophrenia Consortium: Rare Chromosomal Deletions and Duplications Increase Risk of Schizophrenia,” Nature 455, 237 (2008).
B. Xu, J. L. Roos, S. Levy, et al., “Strong Association of De Novo Copy Number Mutations with Sporadic Schizophrenia,” Nat. Genet. 40, 880 (2008).
S. Borinskaya, N. Kal’ina, A. Marusin, et al., “Distribution of Alcohol Dehydrogenase ADH1B*47His Allele in Eurasia,” Am. J. Hum. Genet. 84, 89 (2009).
E. I. Rogaev, “Small RNAs in Human Brain Development and Disorders,” Biokhim. 71(1), 127 (2006) [Biochem. 70, 1404 (2005)].
E. I. Rogaev, D. V. Islamgulov, and A. P. Grigorenko, “MicroRNA in Neuropsychiatric Diseases,” in Current Perspectives in MicroRNAs (MiRNA), Ed. by S.-Y. Ying (Springer Science + Business Media, 2008).
U. A. Meyer, “Pharmacogenetics: Five Decades of Therapeutic Lessons from Genetic Diversity,” Nat. Rev. Genet. 5, 669 (2004).
P. Kumar, H. Wu, J. L. McBride, K. E. Jung, et al., “Transvascular Delivery of Small Interfering RNA to the Central Nervous System,” Nature 448, 39 (2007).
M. Aouadi, G. J. Tesz, S. M. Nicoloro, et al., “Orally Delivered SiRNA Targeting Macrophage Map4k4 Suppresses Systemic Inflammation,” Nature 458, 1180 (2009).
Additional information
Original Russian Text © E.I. Rogaev, 2010, published in Vestnik Rossiiskoi Akademii Nauk, 2010, Vol. 80, No. 5–6, pp. 488–497.
Rights and permissions
About this article
Cite this article
Rogaev, E.I. Genetic approaches to the study of brain functions and mental diseases. Her. Russ. Acad. Sci. 80, 271–278 (2010). https://doi.org/10.1134/S1019331610030135
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1019331610030135